Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Medial vestibular nucleus (MVN) is a prominent anatomical structure located in the floor of the fourth ventricle within the medulla and pons (StatPearls, 2023). It serves as a primary relay station for sensory information originating from the semicircular canals of the inner ear, playing a fundamental role in the vestibulo-ocular reflex (VOR) to maintain visual stability during head motion (Wikipedia, 2024). Beyond gaze stabilization, the MVN contributes to vestibulospinal pathways that regulate posture and balance (NIH, 2022). Pathological changes or imbalances in neuronal activity within the MVN are central to the pathophysiology of vestibular disorders such as vertigo and motion sickness (PubMed, 2021). Pharmacological intervention typically involves the use of vestibular suppressants that target various receptors (e.g., H1, mAChR, GABA-A) expressed on MVN neurons to dampen overactive signaling and alleviate symptoms (Journal of Vestibular Research, 2020). The MVN is also involved in the integration of multisensory inputs, including visual and proprioceptive information, to provide a coherent sense of spatial orientation (NIH, 2022).
Vestibular suppressants act by modulating neurotransmitter systems within the nucleus, including histaminergic (H1), cholinergic (muscarinic), and GABAergic pathways, to reduce the firing rate and excitability of vestibular neurons (StatPearls, 2023; PubMed, 2021).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Medial vestibular nucleus (MVN).